What are Recursion Pharmaceuticals, Inc.'s profit margins?

Recursion Pharmaceuticals, Inc. (RXRX) runs a 7.2% gross margin and a -881.3% operating margin, with a -842.9% net margin.

Where do Recursion Pharmaceuticals, Inc.'s ratios come from?

Every ratio is computed from Recursion Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Recursion Pharmaceuticals, Inc. RXRX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Operating margin	-881.3%-13.5pp	-867.9%+788pp	-1,656.2%-650pp	-1,005.8%-45.7pp	-960.1%-146pp
Net margin	-842.9%+20.4pp	-863.4%+774pp	-1,637.8%-633pp	-1,004.9%-43.6pp	-961.3%-173pp
EBITDA margin	-754.8%+1.0pp	-755.8%+724pp	-1,479.5%-572pp	-907.8%-28.7pp	-879.1%-127pp
Free cash flow margin	-490.7%+15.8pp	-506.5%+518pp	-1,024.7%-415pp	-609.7%+55.4pp	-665.2%-31.5pp
Returns
Return on equity	-57.2%+2.4pp	-59.5%+31.5pp	-91.1%-4.7pp	-86.3%-0.2pp	-86.1%-24.2pp
Return on assets	-42.3%+1.8pp	-44.1%+23.2pp	-67.3%-4.8pp	-62.5%-0.8pp	-61.7%-17.6pp
Return on invested capital	-118.2%+6.4pp	-124.6%+85.2pp	-209.8%-28.7pp	-181.1%-14.3pp	-166.8%-25.8pp
Efficiency
Asset turnover	0.1×0.0×	0.1×0.0×	0×0.0×	0.1×0.0×	0.1×0.0×
Liquidity
Current ratio	5.5×0.0×	5.5×+0.9×	4.6×+1.0×	3.6×-0.5×	4.1×+0.3×
Quick ratio	5.5×0.0×	5.5×+0.9×	4.6×+1.0×	3.6×-0.5×	4.1×+0.3×
Cash ratio	5.1×0.0×	5.1×+0.8×	4.3×+1.0×	3.3×-0.3×	3.6×+0.4×
Leverage
Debt-to-equity	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Debt-to-assets	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Per Share
Book value per share	$1.94-23.4%	$2.53+7.9%	$2.34+6.4%	$2.20-5.0%	$2.32-38.6%
Valuation
Market capitalization	$1.62B-23.8%	$2.13B-0.1%	$2.13B+0.4%	$2.12B-0.2%	$2.13B-19.5%
Enterprise value	$1.04B-29.0%	$1.47B-6.1%	$1.57B-7.8%	$1.7B-2.1%	$1.73B-20.2%
Price / sales	24.4×-4.1×	28.5×-20.3×	48.8×+15.9×	32.8×-2.7×	35.6×-9.3×
Price / book	1.6×-0.3×	1.9×-0.2×	2×-0.3×	2.3×0.0×	2.3×-0.3×
EV / sales	15.7×-4.0×	19.7×-16.1×	35.8×+9.5×	26.3×-2.7×	29×-7.9×
Free cash flow yield	-20.1%-2.3pp	-17.8%+3.2pp	-21%-2.5pp	-18.6%+0.1pp	-18.7%-4.6pp
Earnings yield	-34.5%-4.2pp	-30.3%+3.3pp	-33.6%-3.0pp	-30.6%-3.6pp	-27%-9.5pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Recursion Pharmaceuticals, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Recursion Pharmaceuticals, Inc.'s profit margins?: Recursion Pharmaceuticals, Inc. (RXRX) runs a 7.2% gross margin and a -881.3% operating margin, with a -842.9% net margin.
Where do Recursion Pharmaceuticals, Inc.'s ratios come from?: Every ratio is computed from Recursion Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.